Background: Mite allergen vaccines are important diagnostic and immunothera
peutic reagents. Previous studies on mite allergen stability under differen
t storage conditions have yielded contradictory results,
Objective: We sought to compare, over a 12-month period, the stability of m
ite allergens reconstituted in 50% glycerol and stored at different tempera
tures and to examine the role of protease inhibitors in enhancing allergen
stability.
Methods: Lyophilized allergen extracts were reconstituted in 50% glycerol,
with and without protease inhibitors, and stored at -70 degrees C, -20 degr
ees C, 4 degrees C, or 37 degrees C for 12 months. At 6 and 12 months, the
extracts were compared with freshly dissolved extracts by competition ELISA
with pooled allergic sera, 2-site ELISA with mite-specific mAbs, and immun
oblot analyses,
Results: The overall potencies of the stored extracts measured by competiti
on ELISA were stable at -20 degrees C and 4 degrees C. As determined by mea
ns of the immunoblot and 2-site ELISA, Der fl levels decreased at 4 degrees
C. Levels of Der f 2, Der p 1, and Der p 2 decreased in at least one of th
e allergen-specific assays. Storage at 37 degrees C led to overall loss of
potency and allergen content, whereas storage at -70 degrees C was associat
ed with a moderate loss of potency that increased with multiple freeze-thaw
cycles, Protease inhibitors had no effect on allergen stability.
Conclusion: Although overall potency of the extracts, as measured by compet
ition ELISA, was preserved at -20 degrees C and 4 degrees C, allergen-speci
fic assays indicated loss of allergens. These findings suggest that the com
petition ELISA is insensitive to decreases in the concentrations of individ
ual allergens.